Eversept Partners, LP — 13F Holdings & Portfolio
CIK 1697013 · latest 13F-HR filed 2026-05-15
Eversept Partners, LP manages $1.90B in 13F-reported U.S. long-equity assets across 120 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are UTHR (8.26%), QQQ (7.26%), ABVX (5.49%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 32 new positions, exited 31, added to 24, and trimmed 42.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$1.90B
Long-equity book
120
Distinct positions
2026-03-31
Filed 2026-05-15
+32 / −31 / ↑24 / ↓42
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- BROOKDALE SR LIVING INC$44.8M +1106.7%
- UNITED THERAPEUTICS CORP DEL$33.6M +27.3%
- CELLDEX THERAPEUTICS INC NEW$17.7M +45.5%
- ABIVAX SA$15.3M +17.3%
- INSULET CORP$8.9M +41.8%
Top Trims
- VERA THERAPEUTICS INC-$68.2M -43.8%
- VIRIDIAN THERAPEUTICS INC-$41.5M -74.8%
- GSK PLC-$32.9M -25.0%
- BRUKER CORP-$32.7M -88.6%
- TRAVERE THERAPEUTICS INC-$28.8M -64.1%
New Positions
- WELLTOWER INC$35.8M
- HEALTHPEAK PROPERTIES INC$32.5M
- OMEGA HEALTHCARE INVS INC$25.7M
- QIAGEN NV$21.8M
- REPLIGEN CORP$14.2M
Exited Positions
- DANAHER CORPORATION$42.6M
- EXACT SCIENCES CORP$24.5M
- CIDARA THERAPEUTICS INC$21.8M
- TEVA PHARMACEUTICAL INDS LTD$20.6M
- UNITEDHEALTH GROUP INC$20.1M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $156.7M | 8.26% | 264,271 | SH |
| 2 | INVESCO QQQ TR Put | QQQ | 46090E103 | $137.8M | 7.26% | 238,700 | SH |
| 3 | ABIVAX SA | ABVX | 00370M103 | $104.0M | 5.49% | 934,423 | SH |
| 4 | GSK PLC | GSK | 37733W204 | $98.5M | 5.20% | 1,785,175 | SH |
| 5 | VERA THERAPEUTICS INC | VERA | 92337R101 | $87.4M | 4.61% | 2,173,286 | SH |
| 6 | NATERA INC | NTRA | 632307104 | $76.9M | 4.06% | 384,713 | SH |
| 7 | STATE STR SPDR S&P 500 ETF T Put | SPY | 78462F103 | $69.6M | 3.67% | 107,000 | SH |
| 8 | SYNDAX PHARMACEUTICALS INC | SNDX | 87164F105 | $67.4M | 3.55% | 2,885,622 | SH |
| 9 | CELLDEX THERAPEUTICS INC NEW | CLDX | 15117B202 | $56.7M | 2.99% | 1,788,016 | SH |
| 10 | VAXCYTE INC | PCVX | 92243G108 | $53.7M | 2.83% | 924,193 | SH |
| 11 | BROOKDALE SR LIVING INC | BKD | 112463104 | $48.8M | 2.57% | 3,568,555 | SH |
| 12 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $47.5M | 2.50% | 632,100 | SH |
| 13 | VERTEX PHARMACEUTICALS INC Call | VRTX | 92532F100 | $40.2M | 2.12% | 90,000 | SH |
| 14 | HCA HEALTHCARE INC | HCA | 40412C101 | $37.5M | 1.98% | 79,229 | SH |
| 15 | ISHARES TR Put | TLT | 464287432 | $37.2M | 1.96% | 428,800 | SH |
| 16 | WELLTOWER INC | WELL | 95040Q104 | $35.8M | 1.89% | 180,953 | SH |
| 17 | HEALTHPEAK PROPERTIES INC | DOC | 42250P103 | $32.5M | 1.72% | 1,981,070 | SH |
| 18 | INSULET CORP | PODD | 45784P101 | $30.1M | 1.59% | 143,546 | SH |
| 19 | BIOCRYST PHARMACEUTICALS INC | BCRX | 09058V103 | $28.9M | 1.53% | 3,039,820 | SH |
| 20 | GERON CORP | GERN | 374163103 | $28.1M | 1.48% | 18,834,883 | SH |
| 21 | OMEGA HEALTHCARE INVS INC | OHI | 681936100 | $25.7M | 1.35% | 585,680 | SH |
| 22 | LIQUIDIA CORPORATION | LQDA | 53635D202 | $25.6M | 1.35% | 677,392 | SH |
| 23 | COMMUNITY HEALTH SYS INC NEW | CYH | 203668108 | $25.5M | 1.35% | 8,677,281 | SH |
| 24 | AVANTOR INC | AVTR | 05352A100 | $23.3M | 1.23% | 2,974,287 | SH |
| 25 | QIAGEN NV | QGEN | N72482156 | $21.8M | 1.15% | 545,330 | SH |
| 26 | QIAGEN NV Call | QGEN | N72482156 | $19.1M | 1.01% | 476,300 | SH |
| 27 | ENCOMPASS HEALTH CORP | EHC | 29261A100 | $18.8M | 0.99% | 194,104 | SH |
| 28 | ELI LILLY & CO | LLY | 532457108 | $17.5M | 0.92% | 19,000 | SH |
| 29 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $16.1M | 0.85% | 542,610 | SH |
| 30 | INSMED INC Call | INSM | 457669307 | $15.4M | 0.81% | 94,000 | SH |
| 31 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F105 | $15.0M | 0.79% | 3,188,514 | SH |
| 32 | ISHARES TR Put | HYG | 464288513 | $14.3M | 0.76% | 180,000 | SH |
| 33 | REPLIGEN CORP | RGEN | 759916109 | $14.2M | 0.75% | 120,785 | SH |
| 34 | BETA BIONICS INC | BBNX | 08659B102 | $14.2M | 0.75% | 1,414,838 | SH |
| 35 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $14.0M | 0.74% | 713,269 | SH |
| 36 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 03969K108 | $13.6M | 0.72% | 576,580 | SH |
| 37 | ARDELYX INC | ARDX | 039697107 | $13.4M | 0.70% | 2,229,446 | SH |
| 38 | LTC PPTYS INC | LTC | 502175102 | $11.9M | 0.63% | 321,046 | SH |
| 39 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $11.7M | 0.62% | 207,768 | SH |
| 40 | CHEMED CORP NEW | CHE | 16359R103 | $11.7M | 0.62% | 31,057 | SH |
| 41 | PHARVARIS N V | PHVS | N69605108 | $11.5M | 0.61% | 406,960 | SH |
| 42 | UNITEDHEALTH GROUP INC Call | UNH | 91324P102 | $10.8M | 0.57% | 40,000 | SH |
| 43 | ISHARES TR Put | IWM | 464287655 | $9.9M | 0.52% | 40,000 | SH |
| 44 | PENNANT GROUP INC | PNTG | 70805E109 | $9.5M | 0.50% | 312,178 | SH |
| 45 | SELECT SECTOR SPDR TR Put | XLK | 81369Y803 | $9.3M | 0.49% | 70,000 | SH |
| 46 | NEWAMSTERDAM PHARMA COMPANY | NAMS | N62509109 | $9.1M | 0.48% | 285,764 | SH |
| 47 | PALISADE BIO INC | PALI | 696389402 | $8.7M | 0.46% | 4,987,499 | SH |
| 48 | MODERNA INC | MRNA | 60770K107 | $8.1M | 0.43% | 159,708 | SH |
| 49 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $7.8M | 0.41% | 239,110 | SH |
| 50 | ICON PLC | ICLR | G4705A100 | $7.6M | 0.40% | 68,688 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $1.90B | 120 | 0001697013-26-000003 |
| 2025-12-31 | 2026-02-17 | $1.98B | 107 | 0001697013-26-000002 |
| 2025-09-30 | 2025-11-14 | $1.45B | 86 | 0001697013-25-000010 |